Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells

Caspase-7 uses RNA to enhance proteolysis of poly(ADP-ribose) polymerase 1 and other RNA-binding proteins

(2019) Alexandre Desroches et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies

(2019) N. I. Noguera et al.   Cancers

XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair

(2018) Wynand P. Roos et al.   CANCER LETTERS

Noxa: Role in Cancer Pathogenesis and Treatment

(2018) Rami Z. Morsi et al.   CURRENT CANCER DRUG TARGETS

Acute myeloid leukaemia

(2018) Nicholas J Short et al.   LANCET

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Diastereoselective Synthesis of Biologically Active Cyclopenta[b]indoles

(2016) Marilia S. Santos et al.   JOURNAL OF ORGANIC CHEMISTRY

Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments

(2016) Rong Biaoxue et al.   Journal of Translational Medicine

‘Acute myeloid leukemia: a comprehensive review and 2016 update’

(2016) I De Kouchkovsky et al.   Blood Cancer Journal

Stathmin 1 in normal and malignant hematopoiesis

(2015) Joao Agostinho Machado-Neto et al.   BMB Reports

CHK2 kinase in the DNA damage response and beyond

(2014) L. Zannini et al.   Journal of Molecular Cell Biology

Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kB-dependent signaling

(2013) Paola Castri et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

(2013) E. M. Rego et al.   BLOOD

Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells

(2013) João Agostinho Machado-Neto et al.   LEUKEMIA RESEARCH

Multistep One-Pot Synthesis of Enantioenriched Polysubstituted Cyclopenta[b]indoles

(2011) Biao Xu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Stathmin: a protein with many tasks. New biomarker and potential target in cancer

(2011) Barbara Belletti et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Curing All Patients with Acute Promyelocytic Leukemia: Are We There Yet?

(2011) Muhamed Baljevic et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Indoloditerpenes from an algicolous isolate of Aspergillus oryzae

(2010) Ming-Feng Qiao et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Antioxidant activity of 5,10-dihydroindeno[1,2-b]indoles containing substituents on dihydroindeno part

(2009) Oktay Talaz et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator

(2009) Hassen Ratni et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Indole−Diterpenes and Ergot Alkaloids in Cynodon dactylon (Bermuda Grass) Infected with Claviceps cynodontis from an Outbreak of Tremors in Cattle

(2009) Silvio Uhlig et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

The Lecanindoles, Nonsteroidal Progestins from the Terrestrial FungusVerticillium lecanii6144

(2009) Deborah M. Roll et al.   JOURNAL OF NATURAL PRODUCTS

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

(2008) M. A. Sanz et al.   BLOOD

Acute promyelocytic leukemia: from highly fatal to highly curable

(2008) Z.-Y. Wang et al.   BLOOD

Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and Welwitindolinonesviaa Redox Economic Approach

(2008) Jeremy M. Richter et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY